• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Host Microbe . Molecular basis of 60 years of antigenic evolution of human influenza A(H3N2) virus neuraminidase

tetano

Editor, Senior Moderator
Cell Host Microbe


. 2026 Jan 14;34(1):103-115.e9.
doi: 10.1016/j.chom.2025.12.006.
Molecular basis of 60 years of antigenic evolution of human influenza A(H3N2) virus neuraminidase

Miruna E Rosu[SUP] 1 [/SUP], Kim B Westgeest[SUP] 1 [/SUP], Miranda de Graaf[SUP] 1 [/SUP], Blake M Hauser[SUP] 2 [/SUP], Sina Tureli[SUP] 2 [/SUP], Sarah James[SUP] 2 [/SUP], Felisita F Sinartio[SUP] 1 [/SUP], Theo M Bestebroer[SUP] 1 [/SUP], Pascal Lexmond[SUP] 1 [/SUP], Mark R Pronk[SUP] 1 [/SUP], Stefan van der Vliet[SUP] 1 [/SUP], Eugene Skepner[SUP] 2 [/SUP], Monique I J Spronken[SUP] 1 [/SUP], Barbara Mühlemann[SUP] 3 [/SUP], Mathilde Richard[SUP] 1 [/SUP], Terry C Jones[SUP] 3 [/SUP], Derek J Smith[SUP] 2 [/SUP], Sander Herfst[SUP] 1 [/SUP], Ron A M Fouchier[SUP] 4 [/SUP]


Affiliations
Abstract

Human influenza A viruses escape antibody-mediated immunity through changes in the hemagglutinin (HA) and neuraminidase (NA) glycoproteins. HA antigenic evolution has been studied extensively, with more recent interest in NA due to its importance in influenza vaccine efficacy. Here, the antigenic properties of the NA of more than 300 A(H3N2) and A(H2N2) viruses isolated since 1957 were quantified with a NA inhibition enzyme-linked lectin assay and visualized using antigenic cartography, with follow-up molecular studies using recombinant viruses. The antigenic evolution of N2 NA was more gradual than that described for H3 HA, and antigenic changes in NA and HA were discordant. Multiple substitutions around the NA active site and tetramer lateral side that alter the charge, volume, or hydropathy of amino acids collectively determined antigenic properties. These data facilitate sequence-based genomic surveillance and inference of antigenic phenotypes from genotypes and offer opportunities to improve influenza vaccine effectiveness through increased focus on NA.

Keywords: antigenic drift; evolution; influenza virus; neuraminidase; vaccines.

 
Back
Top Bottom